Velocity Clinical Research

Velocity Clinical Research

Face of Clinical Research

Velocity Clinical Research is a global leader in clinical trials, partnering with pharmaceutical and biotechnology companies to develop groundbreaking drugs, medical devices, and diagnostics that enhance human health. With a network of fully-integrated research sites across the U.S. and Europe, Velocity delivers comprehensive solutions, connecting the right patients, investigators, and staff to advance clinical trials efficiently and effectively.

The New Orleans research site, established in 2012 as MedPharmics and acquired by Velocity in 2022, has earned a reputation for excellence, particularly in Infectious Diseases and Women’s Health. With over 50 vaccine trials successfully completed, the site is now expanding its focus to include new therapeutic areas, better serving the diverse population of the greater New Orleans area.

Conveniently located off S. Norman C. Francis Parkway near the University Medical Center on Tulane Avenue, Velocity Clinical Research New Orleans ensures all trials adhere to ICH, FDA, and GCP guidelines, maintaining the highest standards in clinical research.

Committed to compassionate care, the New Orleans team serves as a trusted resource for study volunteers, offering exceptional patient care and fostering community trust. Velocity’s mission is to advance medicine while improving the lives of participants and the wider community.

Through its dedication to innovation, quality, and patient-centered research, Velocity Clinical Research continues to shape the future of healthcare, providing hope and new treatment possibilities to people worldwide.